drugset / Trial / NCT00571064

The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

NCT00571064

Phase 4 Completed 97 enrolled Eisai Inc. Pfizer · collab
NaSingle-groupOpen-labelTreatment

Summary

This is a study to determine the effectiveness and safety of donepezil hydrochloride (E2020) used to treat residents of assisted living facilities diagnosed with mild, moderate, or severe stage Alzheimer's disease.

Timeline

Start
2008-01
Primary completion
2008-12
Completion
2009-04-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg

Indications